SS-31 peptideside effects The scientific community is increasingly focused on mitochondria-targeting peptides as novel therapeutic agents, and at the forefront of this research is SS-31SS-31 (Elamipretide) - Revitalize Mitochondrial Health. Also known by its development codes MTP-131, Bendavia, and its clinical name Elamipretide, SS-31 is a small peptide that has demonstrated significant promise in addressing a range of cellular dysfunctions, particularly those associated with aging and disease. This article delves into what SS-31 is, its mechanism of action, and its potential applications, drawing upon extensive research and clinical observations.
What is SS-31?
SS-31 is a synthetic tetrapeptide compound with the amino acid sequence D-Arg-2'6'-dimethylTyr-Lys-Phe-NH2. Its defining characteristic is its ability to specifically target and accumulate within the mitochondria, the powerhouses of our cells. This targeted accumulation is crucial for its therapeutic effectsElamipretide Synthetic Hormone. Unlike many other molecules, SS-31 is designed to penetrate cell membranes and then selectively concentrate in the inner mitochondrial membranePerformance Medical Clinic - Education. This unique property allows it to directly interact with key mitochondrial componentsSS-31.
Mechanism of Action: Targeting the Heart of Cellular Energy
The primary mechanism by which SS-31 exerts its effects is by interacting with cardiolipin, a vital phospholipid found predominantly in the inner mitochondrial membrane. This interaction is not merely passive; SS-31 binds selectively to cardiolipin, influencing the structure and function of the membrane. This binding is instrumental in several key processes:
* Stabilizing the Electron Transport Chain (ETC): The ETC is a series of protein complexes embedded in the inner mitochondrial membrane responsible for generating ATP, the cell's main energy currency.SS-31 (also known as Elamipretide®, Bendavia®, and ... SS-31 helps to stabilize the ETC, ensuring its efficient operationSS-31is a synthetic tetrapeptide designed to target and accumulate within the inner mitochondrial membrane. It binds selectively to cardiolipin..
* Reducing Mitochondrial Reactive Oxygen Species (ROS) Production: A byproduct of normal cellular respiration, ROS can become harmful when produced in excess, leading to oxidative stress and cellular damageMitochondrial protein interaction landscape of SS-31 - PNAS. SS-31 acts as a potent mitochondria-targeting antioxidant, actively scavenging these damaging molecules. By reducing mitochondrial ROS production, it protects cellular components from oxidative harm.Elamipretide (aka SS31), brand name FORZINITY™ for Barth Syndrome,is a tetrapeptide compoundbeing developed by Stealth Therapeutics.
* Improving Mitochondrial Quality and Function: Through its antioxidant and stabilizing effects, SS-31 contributes to overall mitochondrial quality, enhancing cellular energy production and promoting cellular repair. This leads to improved mitochondrial functionElamipretide (aka SS31), brand name FORZINITY™ for Barth Syndrome,is a tetrapeptide compoundbeing developed by Stealth Therapeutics..
Research has shown that SS-31 can restore redox homeostasis, a critical balance between oxidants and antioxidants within the cell. This restoration is vital for maintaining healthy cellular processes and preventing age-related decline.
Potential Applications and Benefits
The targeted action of SS-31 on mitochondria has opened doors to its potential use in a wide array of conditions. Its ability to improve energy production and reduce oxidative stress makes it a promising candidate for treating multiple aging-related changes.SS-31 Targets NOS2 to Enhance Osteogenic Differentiation in Aged ... Some of the key areas of investigation include:
* Cardiovascular Health: Studies have indicated that SS-31 can ameliorate kidney injury and improve cardiac function, suggesting its potential in treating cardiovascular diseases.SS-31 (also known as Bendavia, Elamipretide, and MTP-131) isa small peptide that accumulates in mitochondria and scavenges reactive oxygen species.
* Neurological Disorders: The brain is highly dependent on efficient mitochondrial function. SS-31's ability to enhance mitochondrial energy production and reduce oxidative stress holds promise for neuroprotective strategies and addressing age-related cognitive decline.
* Metabolic Disorders: By improving energy metabolism within cells, SS-31 may play a role in managing metabolic conditions.The mitochondria-targeted peptide SS-31 binds lipid ...
* Barth Syndrome: SS-31, under the brand name Forzinity, is a medication used for the treatment of Barth syndrome, a rare genetic disorder that affects mitochondrial function. This highlights its established therapeutic value in specific conditions.
* General Anti-Aging and Cellular Rejuvenation: As a mitochondria-penetrating peptide that supports energy and cellular repair, SS-31 is being explored for its broader anti-aging benefits, aiming to enhance overall vitality and resilience.
Furthermore, research into the mitochondrial protein interaction landscape of SS-31 continues to uncover new pathways through which it exerts its beneficial effects. For instance, it has been shown to target NOS2 to enhance osteogenic differentiation in aged bone, suggesting applications in bone health.
Understanding the Research and Development Landscape
The development and study of SS-31 have been extensive, with numerous peer-reviewed publications documenting its properties and effects. The Szeto-Schiller peptide SS31 has been a subject of significant scientific inquiry since its early investigation. While often referred to as a supplement, it is important to note that Elamipretide (the clinical name for SS-31) is a pharmaceutical compound, and its use should be guided by medical professionals.
The scientific literature consistently points to SS-31 as a water-soluble mitochondria-targeting peptide with a unique capacity to accumulate within mitochondria and scavenge reactive oxygen species. Its mechanism of action, involving the stabilization of the electron transport chain and modulation of mitochondrial membrane electrostatics, underpins its therapeutic potential.
Conclusion
SS-31, or Elamipretide, represents a significant advancement in the field of mitochondrial therapeutics.Targeting Mitochondria by SS-31 Ameliorates the Whole Body ... - NIH As a unique peptide that specifically targets mitochondria, it offers a novel approach to addressing a wide range of health conditions characterized by mitochondrial dysfunction and oxidative stress. Its proven ability to improve mitochondrial function, increasing ATP production, and its role as a mitochondria-targeting antioxidant position it as a molecule of immense therapeutic promise, with ongoing research poised to further unlock its full potential in regenerative medicine and beyond.
Join the newsletter to receive news, updates, new products and freebies in your inbox.